Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1882-1889

  Nihrane, Abdallah ^a   Fujita, Kazunobu ^a   Willey, Ron ^a   Lyu, Myung Soo ^a   Silver, Jonathan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; ENVELOPE PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; HEMATOPOIETIC CELL; IN VITRO STUDY; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TRANSGENIC MOUSE; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS INTERFERENCE; VIRUS RESISTANCE;

EID: 0030067703     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1882-1889.1996     Document Type: Article

References (42)

1. Anderson, S. J., M. Lenburg, N. R. Landau, and J. V. Garcia. 1993 Net from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 67:4923-4931
2. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis J. Exp. Med. 176:1109-1116.
3. Belshi, R. B., M. L. Clements, R. Dolin, B. S. Graham, J. McElrath, G. J. Gorse, D. Schwartz, M. C. Keefer, P. Wright, L. Corey, D. P. Bolognesi, T. J. Matthews, D. M. Stablein, F. S. O'Brien, M. Eibl, F. Dorner, W. Koff, and the NIAID AIDS Vaccine Evaluation Group Network. 1993 Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type I vaccine in subjects at low risk of infection. J. Infect Dis 168:1387-1395.
4. Brady, H. J. M., D. J. Pennington, C. G. Miles, and E. A. Dzierzak. 1993. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J. 12:4923-4932.
5. Byrn, R. A., J. Mordenti, C. Lucas, D. Smith, S. A. Marsters, J. S. Johnson, P. Cossum, S. M. Chamow, F. M. Wurm, T. Gregory, J. E. Groopman, and D. J. Capon. 1990 Biological properties of a CD4 immunoadhesin Nature (London) 344:667-670.
6. Capon, D. J., and R. H. Ward. 1991. The CD4-gp120 interaction and AIDS pathogenesis. Annu. Rev. Immunol. 9:649-678
7. Crise, B., L. Buonocore, and J. K. Rose. 1990. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor J. Virol. 64:5585-5593.
8. Deen, K. C., J. S. McDougal, R. Inacker, G. Folena-Wasserman, J. Arthos, J. Rodenberg, P. J. Maddon, R. Axel, and R. W. Sweet. 1988 A soluble form of CD4 (T4) protein inhibits AIDS virus infection Nature (London) 331:82-84.
9. Del Villano, B. C., and R. A. Lerner. 1976. Relationship between the oncornavirus gene product gp70 and a major protein secretion of the mouse genital tract. Nature (London) 259:497-499.
10. Fisher, R. A., J. M. Bertonis, W. Meier, V. A. Johnson, D. Costopoulos, S. T. Liu, R. Tizard, B. D. Walder, M. S. Hirsch, R. T. Schooley, and R. A. Flavell. 1988. HIV infection is blocked in vitro by recombinant soluble CD4. Nature (London) 331:76-78.
11. Graham, F. L., and A. J. van der Eb. 1973. A new technique for assay of infectivity of human adenovirus 5 DNA. Virology 52:456-457
12. Hussey, R. E., N. E. Richardson, M. Kowalski, N. R. Brown, H. C. Chang, R. F. Siliciano, T. Dorfman, B. Walker, J. Sodroski, and E. L. Reinherz. 1988. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (London) 331:78-81.
13. 12a.Ikeda, H. Personal communication.
14. Ikeda, H., and T. Odaka. 1983. Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlated with Fv-4 gene-controlled resistance to Friend leukemia virus infection Virology 128:127-139.
15. 13a.Ikeda, H., and T. Odaka. 1984 A cell membrane ''gp70" associated with Fv4 gene. immunological characterization and tissue and strain distubution. Virology 133:65-76.
16. Ikeda, H., and H. Sugimura. 1989 Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J. Virol. 63:5405-5412.
17. Jabbar, M. A., and P. D. Nayak. 1990. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J Virol. 64:6297-6304.
18. Jones S. J., and R. Risser. 1993 Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67:67-74.
19. 16a.Kadan, M. J., S. Sturm, W. A. Anderson, and M. A. Eglitis. 1992 Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol 66:2281-2287.
20. r mice. Virology 150:509-512.
21. Kid, M. J., L. B. Crittenden, L. P. Provencher, and S. H. Hughes. 1991. Experimentally introduced defective endogenous proviruses are highly expressed in chickens. J. Virol. 65:313-319
22. Kini J. W., and J. M. Cunningham. 1993 N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells J. Biol Chem 268:16316-16320
23. Kitagawa, M., S. Aizawa, H. Kamisaku, H. Ikeda, K. Hirokawa. and T. Sato. 1995. Cell-free Friend leukemia virus-induced leukemogenesis a unique mechanism for interference with viral infection. Blood 86:1557-1563.
24. Kitagawa, M., H. Kamisaku, S. Aizawa, and T. Sato. 1994 Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia. a model of bone marrow transportation therapy against retroviral infection. Leukemia 8:2200-2206.
25. Kovacs, J. A., M. B. Vasudevanchari, M. Easter, R. T. Davey, J. Falloon, M. A. Polis, J. A. Metcalf, N. Salzman, M. Baseler, G. E. Smith, F. Volvovitz, H. Masur, and H. C. Lane. 1993. Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160. J. Clin. Invest. 92:919-928
26. Kowalski, M., L. Bergeron, R. Dorfman, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 Science 237:1351-1355
27. Lander, M. R., B. Moll, and W. P. Rowe. 1978 A procedure for culture of cells from mouse tail biopsies J. Natl. Cancer Inst. 60:477-178.
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
29. Lee, M. R., D. D. Ho, and M. E. Gurney. 1987. Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science 237:1047-1051.
30. Lerner, R. A., C. B. Wilson, B. C. Villano, P. T. McConahey, and F. J. Dixon. 1976 Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histological and physiologic studies of the major glycoprotein gp70. J. Exp. Med. 143:151-166.
31. Limjoco, T. I., P. Dickie, H. Ikeda, and J. Silver. 1993. Transgenic Fv-4 mice resistant to Friend virus. J. Virol. 67:4163-4168.
32. Limjoco, T. I., A. Nihrane, and J. Silver. 1995 Resistance to retroviral infection in transgenic and bone marrow chimeric mice containing Fv-4-env expressing hematopoietic cells Virology 208:75-83.
33. a glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc. Natl. Acad. Sci. USA 84:4601.
34. Masuda, M., and H. Yoshikura. 1990. Construction and characterization of the recombinant Moloney murine leukemia viruses bearing the mouse Fv-4 env gene J. Virol. 64:1033-1043.
35. Pinter, A., J. Lieman-Hurwitz, and E. Fleissner. 1978. The nature of the association between the murine leukemia virus envelope proteins. Virology 91:345-351
36. Redfield, R. R., D. L. Birx, N. Ketter, E. Tramont, V. Polonis, C. Davis, J. F. Brundage, G. Smith, S. Johnson, A. Fowler, T. Wierza, A. Schafferman, F. Vulvovitz, C. Oster, D. S. Burke, and the Military Medical Consortium for Applied Retroviral Research. 1991. A phase 1 evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection N. Engl. J. Med. 324:1677-1684.
37. Robinson, H. L., S. M. Astrin, A. M. Senior, and F. H. Salazar. 1981. Host susceptibility to endogenous viruses: defective, glycoprotein-expressing pro-viruses interfere with infections. J. Virol. 40:745-751.
38. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970. Plaque assay technique for murine leukemia viruses Virology 42:1136-1139.
39. Rubin, H. 1960 A virus in chick embryos which induces resistance in vitro to infection with Rous sarcoma virus Proc. Natl. Acad. Sci. USA 46:1105-1119.
40. Spouge, J. L. 1994 Viral multiplicity of attachment and its implications for human immunodeficiency virus therapies J. Virol 68:1782-1789.
41. Wang, H., E. Dechant, M. Kavanaugh, R. A. North, and D. Kabat. 1992. Effects of ecotropic murine retroviruses on the dual-function cell surface receptor/basic ammo acid transporter. J. Biol. Chem. 267:23617-23624.
42. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complex. J. Virol. 66:226-234.